Matt Hewitt
Stock Analyst at Craig-Hallum
(3.85)
# 756
Out of 4,412 analysts
26
Total ratings
58.62%
Success rate
7.56%
Average return
Main Sectors:
14 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CSBR Champions Oncology | Downgrades: Hold | n/a | $5.02 | - | 1 | Mar 13, 2024 | |
| SDGR Schrödinger | Maintains: Buy | $40 → $35 | $23.97 | +46.02% | 2 | Jan 19, 2024 | |
| SLP Simulations Plus | Maintains: Buy | $50 → $51 | $44.69 | +14.12% | 5 | Jan 4, 2024 | |
| AGTI Agiliti | Initiates: Buy | $23 | $10.05 | +128.86% | 1 | Jan 4, 2024 | |
| NOTV Inotiv | Maintains: Buy | $34 → $25 | $4.05 | +517.28% | 1 | Dec 12, 2023 | |
| CDMO Avid Bioservices | Maintains: Buy | $22 → $16 | $7.35 | +117.69% | 3 | Dec 8, 2023 | |
| MXCT MaxCyte | Initiates: Buy | $7 | $3.71 | +88.68% | 1 | Nov 29, 2023 | |
| BLFS BioLife Solutions | Maintains: Buy | $29 → $23 | $17.53 | +31.20% | 2 | Aug 10, 2023 | |
| RGEN Repligen | Maintains: Buy | $207 → $200 | $166.58 | +20.06% | 2 | Aug 3, 2023 | |
| OABI OmniAb | Initiates: Buy | $10 | $4.48 | +123.21% | 1 | Apr 13, 2023 | |
| TDOC Teladoc Health | Maintains: Hold | $67 → $30 | $13.01 | +130.59% | 4 | Apr 28, 2022 | |
| ISPC iSpecimen | Initiates: Buy | $20 | $0.27 | +7,418.80% | 1 | Jan 4, 2022 | |
| OMCL Omnicell | Maintains: Buy | n/a | $27.86 | - | 1 | Nov 3, 2021 | |
| LGND Ligand Pharmaceuticals | Maintains: Buy | n/a | $70.57 | - | 1 | Oct 21, 2020 |
Champions Oncology
Mar 13, 2024
Downgrades: Hold
Price Target: n/a
Current: $5.02
Upside: -
Schrödinger
Jan 19, 2024
Maintains: Buy
Price Target: $40 → $35
Current: $23.97
Upside: +46.02%
Simulations Plus
Jan 4, 2024
Maintains: Buy
Price Target: $50 → $51
Current: $44.69
Upside: +14.12%
Agiliti
Jan 4, 2024
Initiates: Buy
Price Target: $23
Current: $10.05
Upside: +128.86%
Inotiv
Dec 12, 2023
Maintains: Buy
Price Target: $34 → $25
Current: $4.05
Upside: +517.28%
Avid Bioservices
Dec 8, 2023
Maintains: Buy
Price Target: $22 → $16
Current: $7.35
Upside: +117.69%
MaxCyte
Nov 29, 2023
Initiates: Buy
Price Target: $7
Current: $3.71
Upside: +88.68%
BioLife Solutions
Aug 10, 2023
Maintains: Buy
Price Target: $29 → $23
Current: $17.53
Upside: +31.20%
Repligen
Aug 3, 2023
Maintains: Buy
Price Target: $207 → $200
Current: $166.58
Upside: +20.06%
OmniAb
Apr 13, 2023
Initiates: Buy
Price Target: $10
Current: $4.48
Upside: +123.21%
Teladoc Health
Apr 28, 2022
Maintains: Hold
Price Target: $67 → $30
Current: $13.01
Upside: +130.59%
iSpecimen
Jan 4, 2022
Initiates: Buy
Price Target: $20
Current: $0.27
Upside: +7,418.80%
Omnicell
Nov 3, 2021
Maintains: Buy
Price Target: n/a
Current: $27.86
Upside: -
Ligand Pharmaceuticals
Oct 21, 2020
Maintains: Buy
Price Target: n/a
Current: $70.57
Upside: -